Skip to main content
. 2013 May 2;43(1):23–28. doi: 10.3892/ijo.2013.1928

Table II.

Progression-free rates in different sarcoma subgroups.

L-sarcoma Non-L-sarcoma Elderly Non-elderly
n 46 55 23 78
Median PFS 3.1 1.6 2.9 2.1
3 months PFS 51% 36% 42% 43%
6 months PFS 38% 16% 30% 26%
CBR 55% 34% 43% 44%

CBR, clinical benefit rate (NC+PR).